Tag: GeneDX

Cancer Genome Sequencing Market Size, Share, Competitive

According to a new report published by Allied Market Research, Cancer Genome Sequencing Market, Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a…

Continue Reading Cancer Genome Sequencing Market Size, Share, Competitive

Next Generation Sequencing Market Is Anticipated To Grow At

The global Next-generation Sequencing Market was valued at 5.4 billion in 2022 and it is anticipated to grow up to USD 18.7 billion by 2032, at a CAGR of 13.2% during the forecast period. Request free sample copy of this research study: www.globalinsightservices.com/request-sample/GIS10518/?utm_source=pranalipawar&utm_medium=Openpr&utm_campaign=04122023 Next-generation sequencing (NGS) is a type of…

Continue Reading Next Generation Sequencing Market Is Anticipated To Grow At

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript October 30, 2023 Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter 2023 Earnings Conference Call. All participants will be in a…

Continue Reading Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript

Q3 2023 Pacific Biosciences of California Inc Earnings Call

Participants Christian O. Henry; President, CEO & Director; Pacific Biosciences of California, Inc. Susan G. Kim; CFO; Pacific Biosciences of California, Inc. Todd Friedman; Former Director of IR; Pacific Biosciences of California, Inc. Daniel Gregory Brennan; MD and Senior Tools & Diagnostics Analyst; TD Cowen, Research Division Eve Burstein Jack…

Continue Reading Q3 2023 Pacific Biosciences of California Inc Earnings Call

PacBio Announces Third Quarter 2023 Financial Results

MENLO PARK, Calif., Oct. 30, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2023. Third quarter results Revenue of $55.7 million, a 72% increase compared with $32.3 million in the prior-year period. Instrument revenue of $34.7 million compared with $11.4 million in the prior-year…

Continue Reading PacBio Announces Third Quarter 2023 Financial Results

Florida Medicaid will cover genetic tests for undiagnosed kids

Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction. Two weeks later, she had another emergency surgery, and then developed meningitis. Layla spent more than a month in neonatal intensive care in three hospitals as doctors searched for…

Continue Reading Florida Medicaid will cover genetic tests for undiagnosed kids

A quick genetic test offers hope for sick, undiagnosed kids. But few insurers are willing to pay

Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction. Two weeks later, she had another emergency surgery and then developed meningitis. Layla spent more than a month in neonatal intensive care in three hospitals as doctors searched for…

Continue Reading A quick genetic test offers hope for sick, undiagnosed kids. But few insurers are willing to pay

Quick Genetic Test Offers Hope for Sick, Undiagnosed Kids. But Few Insurers Offer to Pay.

Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction. Two weeks later, she had another emergency surgery, and then developed meningitis. Layla spent more than a month in neonatal intensive care in three hospitals as doctors searched for…

Continue Reading Quick Genetic Test Offers Hope for Sick, Undiagnosed Kids. But Few Insurers Offer to Pay.

Three Reasons to Add PacBio (PACB) Stock to Your Portfolio

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its slew of strategic deals over the past few months. The optimism led by a solid second-quarter 2023 performance and its product development activities are expected to contribute further. However, stiff competition and macroeconomic concerns persist….

Continue Reading Three Reasons to Add PacBio (PACB) Stock to Your Portfolio

Despite 3-Week Decline, PacBio Stock Doubles in a Year

Pacific Biosciences of California (PacBio; PACB) investors could be forgiven for having questions about the company’s stock after it sank 26% between August 1–25, from $13.34 to $9.92 despite a flurry of developments that included the raising of its revenue forecast for this year and a growing challenge to longtime…

Continue Reading Despite 3-Week Decline, PacBio Stock Doubles in a Year

Rapid Sequencing Yields High Newborn Epilepsy Diagnostic Rates in Gene-STEPS Study

NEW YORK – Early results of a multinational genomic study of infantile epilepsy found that rapid whole-genome sequencing (WGS) improved diagnostic yield over more common methods, giving hope to those wishing whole-genome testing would become a standard of care for diagnosing and developing treatment plans for genetic disorders in newborns….

Continue Reading Rapid Sequencing Yields High Newborn Epilepsy Diagnostic Rates in Gene-STEPS Study

Lab Professionals Call for Changes in Reporting Variants of Uncertain Significance

NEW YORK – The evidence supporting variants of uncertain significance (VUS) should be considered when determining which VUS to report in diagnostic multi-gene panels, argue scientists from across academic and commercial labs in newly published research. Current laboratory policies typically call for reporting all VUS in diagnostic testing, or when…

Continue Reading Lab Professionals Call for Changes in Reporting Variants of Uncertain Significance

Genomics Market Size, Share, Growth, Outlook 2023-2030

PRESS RELEASE Published August 22, 2023 “Genomics Market – DataM Intelligence” Genomics Market is estimated to grow at a CAGR of 18.7% during the forecast period 2023-2030 Market Overview: The branch of biology known as genomics focuses on understanding an organism’s entire gene or genetic makeup (DNA). It entails deciphering…

Continue Reading Genomics Market Size, Share, Growth, Outlook 2023-2030

Genomic research collaboration | Scientist Live

PacBio, a leading developer of high-quality, highly accurate sequencing solutions and GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, have announced a research collaboration with the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in…

Continue Reading Genomic research collaboration | Scientist Live

PacBio, GeneDx team up to test if long-read sequencing improves pediatric diagnoses

PacBio, GeneDx, and the University of Washington have partnered to study the use of long-read whole genome sequencing (WGS) in the diagnosis of children with genetic conditions. In the study, GeneDx, a genetic testing company, will use PacBio’s Revio sequencing system to perform WGS and analysis of samples from 350…

Continue Reading PacBio, GeneDx team up to test if long-read sequencing improves pediatric diagnoses

GeneDx Q2 Revenues Increase 35 Percent, Boosted by Growth in Exome, Genome Tests

NEW YORK – GeneDx said Tuesday after market close that its second quarter revenues grew nearly 35 percent to $48.7 million from $36.2 million a year ago, boosted by growth in whole-exome and genome sequencing testing revenue. The total beat the Wall Street consensus estimate of $47.6 million. More than…

Continue Reading GeneDx Q2 Revenues Increase 35 Percent, Boosted by Growth in Exome, Genome Tests

70% Of U.S. Adults ‘Concerned’ About AI In Healthcare

InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. 70% of U.S. adults are “concerned” about artificial intelligence in healthcare. getty Around 70% of U.S. adults surveyed by Morning Consult said they are “concerned” about artificial intelligence in healthcare. The most concerned group…

Continue Reading 70% Of U.S. Adults ‘Concerned’ About AI In Healthcare

PacBio (PACB) Inks Research Collaboration for Genome Sequencing – August 9, 2023

Pacific Biosciences of California (PACB Quick QuotePACB – Free Report) , popularly known as PacBio, entered into a research collaboration with the University of Washington. As a part of the research collaboration, PACB, along with GeneDx (WGS Quick QuoteWGS – Free Report) , the leading provider of genomic and clinical…

Continue Reading PacBio (PACB) Inks Research Collaboration for Genome Sequencing – August 9, 2023

GeneDX in partnership to study whole genome sequencing for pediatric patients

Stamford-based GeneDx (NASDAQ:WGS) is partnering with PacBio (NASDAQ: PACB) and the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in pediatric patients with genetic conditions. According to the company, GeneDx will perform WGS sequencing and analysis of samples from 350…

Continue Reading GeneDX in partnership to study whole genome sequencing for pediatric patients

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms  MENLO PARK, Calif. and STAMFORD, Conn., Aug. 7, 2023 /PRNewswire/ — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions and GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes…

Continue Reading PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

Pacific Biosciences, GeneDx, UW Collaborate on Google-Funded Study of WGS in Neonatal Care

NEW YORK – Pacific Biosciences and GeneDx said on Monday that they are collaborating with the University of Washington to study long-read, whole-genome sequencing-based diagnostics in neonatal care. Under the collaboration, with funding from Google, the partners will study the capabilities of PacBio’s HiFi long-read sequencing technology to increase diagnostic…

Continue Reading Pacific Biosciences, GeneDx, UW Collaborate on Google-Funded Study of WGS in Neonatal Care

Pharmacogenomics Market to Garner USD 33.01 Billion Globally, by 2030 at 11.1 % CAGR: Coherent Market Insights

PRESS RELEASE Published July 23, 2023 Report Outline: The purpose of this report is to provide the client with a comprehensive understanding of the Pharmacogenomics Market. It encompasses market definition, segmentation, market drivers, trends, opportunities, and challenges in predominant areas and influential countries. The report is based on extensive research…

Continue Reading Pharmacogenomics Market to Garner USD 33.01 Billion Globally, by 2030 at 11.1 % CAGR: Coherent Market Insights

Genetic Testing Market Surges with Promising Prospects

PRESS RELEASE Published July 22, 2023 The global Genetic Testing Market size is predicted to reach USD 29.44 billion by 2030 with a CAGR of 11.1% from 2020-2030. The report offers valuable business perspectives on various macroeconomic factors impacting the industry and provides an overview of world economies. It delves…

Continue Reading Genetic Testing Market Surges with Promising Prospects

Goldman Sachs Adjusts Price Target on GeneDx to $8 From $9, Maintains Neutral Rating

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company’s segments are GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole…

Continue Reading Goldman Sachs Adjusts Price Target on GeneDx to $8 From $9, Maintains Neutral Rating

GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options

NEW YORK and STAMFORD, Conn., July 19, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, and Prognos Health, the largest real-world integrated data marketplace, today announced a strategic partnership to shorten the treatment odyssey for rare disease patients via real world…

Continue Reading GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options

New Pangenome Bioinformatics Toolkit Offers “Multiscale” View of Variants in Diverse Genomes

NEW YORK – A new set of tools for genome analysis using the concept of the human pangenome is available for researchers, enabling visualization of variants at different scales, from single-nucleotide polymorphisms to large structural variants. In a paper published in Nature Methods this week, researchers led by Jason Chin…

Continue Reading New Pangenome Bioinformatics Toolkit Offers “Multiscale” View of Variants in Diverse Genomes

GeneDx to Present New Data on Urine Mitochondrial DNA

STAMFORD, Conn., June 28, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will present new data on urine mitochondrial DNA testing at the 2023 United Mitochondrial Disease Foundation’s (UMDF) Mitochondrial Medicine Symposium in Charlotte, North Carolina,…

Continue Reading GeneDx to Present New Data on Urine Mitochondrial DNA

AI In Genomics Global Market Report 2023

New York, June 26, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “AI In Genomics Global Market Report 2023” – www.reportlinker.com/p06464018/?utm_source=GNW , Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., and Engine…

Continue Reading AI In Genomics Global Market Report 2023

Decade After SCOTUS Gene Patents Ruling, Precision Medicine and Test Innovation Impact Under Debate

NEW YORK – Ten years ago today, the US Supreme Court deemed that gene sequences, even when isolated from the body, are products of nature that aren’t eligible for patents. A decade later, industry players aren’t of one mind as to whether the outcome of that and other recent patent…

Continue Reading Decade After SCOTUS Gene Patents Ruling, Precision Medicine and Test Innovation Impact Under Debate

Buccal Swab Added as WGS Sample Collection Option

GeneDx announced the availability of its GenomeXpress and GenomeSeqDx whole genome sequencing (WGS) tests with buccal swabs as an alternative sample collection option for biological parents or other immediate family members. Sequencing biological parent genomes alongside patient genomes—known as trio analysis—aids in disease diagnosis and greatly increases diagnostic yield rates. “We…

Continue Reading Buccal Swab Added as WGS Sample Collection Option

Pharmacogenomics Market Is Booming Worldwide 2023-2030

  “Coherent Market Insights offers a 25% discount on Pharmacogenomics Market Reports on Single User Access and Unlimited User Access” Pharmacogenomics Market Size Projections : Global pharmacogenomics market is estimated to be valued at US$ 14,028.01 million in 2022 and is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). Pharmacogenomics, often known as pharmacogenetics, is a branch…

Continue Reading Pharmacogenomics Market Is Booming Worldwide 2023-2030

Neurogenetic Testing Market Worth Observing Growth | GeneDx, Illumina, Labcorp

Global Neurogenetic Testing Market Growth (Status and Outlook) 2023-2029 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of…

Continue Reading Neurogenetic Testing Market Worth Observing Growth | GeneDx, Illumina, Labcorp

Increase in Fetal Chromosomal Abnormalities Drives Growth

DUBLIN, May 24, 2023 /PRNewswire/ — The “Carrier Screening Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global carrier screening market is expected to grow from $2.03 billion in…

Continue Reading Increase in Fetal Chromosomal Abnormalities Drives Growth

GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate

NEW YORK – GeneDx said Tuesday after market close that its first quarter revenues fell 20 percent to $43.1 million from $53.9 million a year ago but easily outstripped the Wall Street consensus estimate of $38.0 million. Almost all revenues in the three months ended March 31 came from diagnostic testing….

Continue Reading GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate

New Products Posted to GenomeWeb: Roche, GeneDx

Roche Kapa HyperExome V2 Probes Roche has launched its Kapa HyperExome V2 Probes, a whole-exome sequencing panel that provides a key update to the company’s Kapa HyperCap Target Enrichment portfolio. The new panel covers recent versions of the ACMGv3.1, RefSeq, CCDS, ClinVar, Ensembl, and COSMIC genomic databases within a compact…

Continue Reading New Products Posted to GenomeWeb: Roche, GeneDx

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing…

Continue Reading GeneDx Adds Buccal Swab as Non-Invasive Whole Genome Sequencing Sample Collection Option

2023-05-04 | NDAQ:WGS | Press Release

New Option Enables Easier DNA Sample Collection from Biological Parents to Aid in Disease Diagnosis STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing…

Continue Reading 2023-05-04 | NDAQ:WGS | Press Release

GeneDx Adds Buccal Swab as Non-Invasive Whole Genome

STAMFORD, Conn., May 04, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced the availability of its GenomeXpress® and GenomeSeqDx® whole genome sequencing tests with buccal swabs as an alternative sample collection option for biological parents or other…

Continue Reading GeneDx Adds Buccal Swab as Non-Invasive Whole Genome

Carrier Screening Global Market Report 2023

New York, April 26, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Carrier Screening Global Market Report 2023” – www.reportlinker.com/p06450944/?utm_source=GNW , Myriad Genetics Inc., Eurofins Scientific SE, OPKO Health Inc., Quest Diagnostics Inc., Luminex Corporation, BGI Genomics, Gene by Gene, OME Care, MedGenome Inc., and Otogenetics Corporation….

Continue Reading Carrier Screening Global Market Report 2023

Whole Exome Sequencing Market Trends, Share, Industry Size, Growth, Demand, Opportunities and Forecast By 2029

PRESS RELEASE Published April 25, 2023 Recent study report released by Data Bridge Market research titled “Global Whole Exome Sequencing Market” (covering USA, Europe, China, Japan, India, South East Asia, etc) highlights opportunities, risk analysis, and leveraged with strategic and tactical decision-making support. This research report presents key insights on…

Continue Reading Whole Exome Sequencing Market Trends, Share, Industry Size, Growth, Demand, Opportunities and Forecast By 2029

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

NEW YORK – As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation service in partnership with genome analysis company Fabric Genomics. Priced at $1,000 per sample, the new…

Continue Reading Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

Validea Kenneth Fisher Strategy Daily Upgrade Report – 3/10/2023

The following are today’s upgrades for Validea’s Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins. HARMONY GOLD MINING CO. (ADR) (HMY) is a small-cap value stock in…

Continue Reading Validea Kenneth Fisher Strategy Daily Upgrade Report – 3/10/2023

Diagnosing Ehlers-Danlos Syndrome (EDS): DNA Testing Guide

A Guide to Ehlers-Danlose Syndrome and DNA Testing This guide offers an in-depth look at how DNA testing can help diagnose Ehlers-Danlos Syndrome (EDS), a rare genetic disorder that affects the body’s connective tissue. The article outlines four key steps to follow when using DNA testing to diagnose EDS, including choosing…

Continue Reading Diagnosing Ehlers-Danlos Syndrome (EDS): DNA Testing Guide

North America Whole Exome Sequencing Market to Grow at an Impressive CAGR of 22.0% by 2029

PRESS RELEASE Published February 15, 2023 Data Bridge Market research has recently released expansive research titled “North America Whole Exome Sequencing Market” guarantees you will remain better informed than your competition. This study provides the broader perspective of the market place with its comprehensive market insights and analysis which eases…

Continue Reading North America Whole Exome Sequencing Market to Grow at an Impressive CAGR of 22.0% by 2029

Gene Panel Market 2023-2028 Remarkably Focusing on Top Market Drivers and Opportunities, Advanced Technologies

Key players are Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd. Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced…

Continue Reading Gene Panel Market 2023-2028 Remarkably Focusing on Top Market Drivers and Opportunities, Advanced Technologies

AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

HOLLYWOOD, Florida – Illumina provided the first explanation for how its new Complete Long Reads (CLR) product will work as well as some customer data and testimonials at a Wednesday workshop here at the Advances in Genome Biology and Technology annual meeting. First, DNA molecules are tagmented to generate long…

Continue Reading AGBT: Illumina Offers First Look Under the Hood for Complete Long Reads Product

VCV000038126.28 Observations – ClinVar – NCBI

1 SCV000301220.2 Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Pathogenic reviewed by expert panel curation Breast-ovarian cancer, familial, susceptibility to, 2 (unknown ) germline Variant allele predicted to encode a truncated non-functional protein. 1 SCV000785901.2 Counsyl Pathogenic criteria provided,single submitter clinical testing Breast-ovarian cancer, familial, susceptibility to,…

Continue Reading VCV000038126.28 Observations – ClinVar – NCBI

VCV000698353.6 – ClinVar – NCBI

Likely benign (Nov 17, 2018) criteria provided, single submitter Method: clinical testing Arrhythmia Affected status: unknown Allele origin: germline Color Health, Inc Accession: SCV001358509.1 Submitted: (May 19, 2020) Likely benign (Apr 19, 2020) criteria provided, single submitter Method: clinical testing Long QT syndrome Affected status: unknown Allele origin: germline Invitae…

Continue Reading VCV000698353.6 – ClinVar – NCBI

VCV000445854.7 Observations – ClinVar – NCBI

1 SCV000610624.1 Center for Pediatric Genomic Medicine,Children’s Mercy Hospital and Clinics Benign criteria provided,single submitter clinical testing not provided (not provided ) germline 1 SCV000700353.2 Eurofins NTD, LLC Uncertain significance criteria provided,single submitter clinical testing 1 not provided (unknown ) germline 1 Single Heterozygote www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=CYP21A2 mixed 1 SCV001137083.1 Mendelics Benign…

Continue Reading VCV000445854.7 Observations – ClinVar – NCBI

GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset the largest of its kind…

Continue Reading GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes

GeneDx Announces the Sequencin – GuruFocus.com

GAITHERSBURG, Md., Sept. 21, 2021 GAITHERSBURG, Md., Sept. 21, 2021 /PRNewswire/ — GeneDx, Inc., a leader in genomic analysis, a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced it has completed clinical genetic exome sequencing for more than 300,000 patients, making the company’s dataset…

Continue Reading GeneDx Announces the Sequencin – GuruFocus.com

Expanding the diagnosis for Xia-Gibbs Syndrome

Xia-Gibbs Syndrome (XGS) is a rare genetic disorder that results in severe developmental delay, sleep apnea, delayed speech and upper body weakness. Image courtesy of the National Human Genome Research Institute In 2014, a team led by Dr. Richard Gibbs, director of the Human Genome Sequencing Center and Wofford Cain Chair and…

Continue Reading Expanding the diagnosis for Xia-Gibbs Syndrome

GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States

GeneDx is a rapidly growing CAP and CLIA certified diagnostic genetic testing laboratory for molecular genetics. Our historic mission has been to make clinical diagnostic testing available for people with genetic conditions and their families. We apply cutting edge technologies that provide a wide array of molecular genetic diagnostic tests,…

Continue Reading GeneDx hiring DNA Sequencing Lab Technician I (FT, 40 Hours, On-site) in Gaithersburg, Maryland, United States